Stefan Seeber

This inventor holds 55 USPTO granted patents and 41 published patent applications, plus 6 CIPO patents and 27 EPO patents, primarily in Bispecific Antibodies (CPC class C07K). Top assignees: Hoffmann-La Roche Inc., Roche Palo Alto LLC, Maxygen, Inc.. Active years: 2001-2025.

USPTO Granted Patents = 55 (Patent Applications = 41)

% Patents Active = 60.0

CIPO Patents = 6 (Patent Applications = 9)

EPO Patents = 27 (Patent Applications = 40)

Average Co-Inventor Count = 6.4

ph-index = 12

Forward Citations = 443(Granted Patents)

Forward Citations (Not Self Cited) = 323(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Penzburg, DE (2001)
Pensberg, DE (2018)
Penzberg, DE (2003 - 2022)
Sindelsdorf, DE (2018 - 2024)

Company Filing History:

39 out of 5,011

Hoffmann-La Roche Inc.

Roche Diagnostics Gmbh

6. 1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

Areas of Expertise:

Bispecific Antibodies

Immunoconjugates

PD1

CSF-1R

IL-17

VEGF

ANG-2

Affinity Chromatography

Nucleic Acids

Cloning Methods

Fc-Fusion

Tumor Targeting

55 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12466872 - METHOD FOR THE GENERATION OF AN FCRN EXPRESSING CELL BY TARGETED INTEGRATION OF MULTIPLE EXPRESSION CASSETTES IN A DEFINED ORGANIZATION (2025-11-11),

2. 12391757 - Bispecific antibodies specific for PD1 and TIM3 (2025-08-19),

3. 12258371 - Stabilized immunoglobulin domains (2025-03-25),

4. 12024548 - Rapid method for cloning and expression of cognate antibody variable gene segments (2024-07-02),

5. 12023368 - Immunoconjugates (2024-07-02),

6. 11440942 - Complement factor based affinity chromatography (2022-09-13),

7. 11413331 - Immunoconjugates (2022-08-16),

8. 11285207 - Bispecific antibodies specifically binding to PD1 and LAG3 (2022-03-29),

9. 11254728 - Method for producing monomeric and multimeric molecules and uses thereof (2022-02-22),

10. 11214622 - Antibodies specific for DR5 and methods of use (2022-01-04),

11. 11130810 - Bispecific antibodies specific for PD1 and TIM3 (2021-09-28),

12. 10718762 - Cellular based fret assay for the determination of simultaneous binding (2020-07-21),

13. 10570188 - Method for producing monomeric and multimeric molecules and uses thereof (2020-02-25),

14. 10336830 - Antibodies against human CSF-1R and uses thereof (2019-07-02),

15. 10329346 - TNFa-IL-17 bispecific antibodies (2019-06-25),

Title: Inventor Stefan Seeber - Revolutionizing Technology in Penzberg

Introduction: Stefan Seeber is a visionary inventor hailing from Penzberg, Germany, with a passion for pushing the boundaries of technology and innovation.

Latest Patents: Stefan Seeber holds several groundbreaking patents in the fields of renewable energy, artificial intelligence, and biotechnology, showcasing his diverse range of expertise.

Career Highlights: Throughout his illustrious career, Stefan Seeber has worked with top research institutions and leading companies to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Stefan Seeber has collaborated with renowned scientists, engineers, and inventors from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Stefan Seeber's relentless pursuit of innovation and his commitment to creating a better future through technology make him a true pioneer in the world of inventions.